Chemoinformaics analysis of 2,3,11,13-Tetrahydrohelenalin
| Molecular Weight | 266.337 | nRot | 0 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 17 |
| Exact Molecular Weight | 266.152 | nRing | 3 |
| Solubility: LogS | -1.925 | nHRing | 1 |
| Solubility: LogP | 1.298 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 42.9274 |
| nHD | 1 | BPOL | 25.5426 |
| QED | 0.676 |
| Synth | 4.499 |
| Natural Product Likeliness | 3.146 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.506 |
| Pgp-sub | 0.109 |
| HIA | 0.008 |
| CACO-2 | -4.656 |
| MDCK | 0.000047 |
| BBB | 0.981 |
| PPB | 0.490661 |
| VDSS | 0.756 |
| FU | 0.544135 |
| CYP1A2-inh | 0.07 |
| CYP1A2-sub | 0.343 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.846 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.126 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.268 |
| CYP3a4-inh | 0.098 |
| CYP3a4-sub | 0.368 |
| CL | 9.427 |
| T12 | 0.877 |
| hERG | 0.052 |
| Ames | 0.016 |
| ROA | 0.573 |
| SkinSen | 0.329 |
| Carcinogencity | 0.159 |
| EI | 0.199 |
| Respiratory | 0.401 |
| NR-Aromatase | 0.073 |
| Antiviral | Yes |
| Prediction | 0.730216 |